Team Finds Better Way to Engineer Therapeutic Proteins into Antibodies

The research, led TSRI’s Richard Lerner and Rockefeller’s Jeffrey Friedman, advanced an obesity therapy as proof-of-principle.

International Team Discovers the Ancient Origins of Deadly Lassa Virus

TSRI Assistant Professor Kristian Andersen and colleagues were surprised to find far-flung strains of Lassa virus share a common ancestor that can be traced back more than 1,000 years.

Scientists Determine How Antibiotic Gains Cancer-Killing Sulfur Atoms

This discovery from the Shen lab has implications for drug development for cancer and other diseases.

Collaboration Leads to First Structure of Crucial Plant Hormone

The study from the Griffin lab and colleagues solved a mystery about proteins playing a crucial role in responding to insects and microorganisms, as well as promoting normal growth and development.

Hands-On Research 101: Internships Introduce Undergrads to Biomedical Science in Action

When undergraduate chemistry major Joshua David saw scientists from TSRI discussing Ebola virus research on the news last year, he wanted to help.

$1.4 Million Grant Funds Study of Drug Candidates for Neurological Disorders and Other Diseases

The Griffin and Kamenecka labs will lead the project, which includes a study of disruptions in circadian rhythm linked to depression, bipolar disease and schizophrenia.